Transforming growth factor-beta (TGF-P) is a polypeptide with multiple physiological functions. lsoforms of this growth factor have important roles in control of the cell cycle, in regulation of cell-cell interactions and in growth and development. Malignant transformation has been shown to be assoc
Relationship between actions of transforming growth factor (TGF)-β and cell surface expression of its receptors in clonal osteoblastic cells
✍ Scribed by Yasuhiro Takeuchi; Seiji Fukumoto; Toshio Matsumoto
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 790 KB
- Volume
- 162
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
✦ Synopsis
Various osteoblastic cell lines were examined for the relationship between the presence of cell-surface transforming growth factor (TGF)-P receptors and the synthesis of matrix proteins with their responsiveness to TGF-P. Treatment with TGF-PI inhibited proliferation and stimulated proteoglycan and fibronectin synthesis in MC3T3-EI and M G 63 cells. The major proteoglycans synthesized by these cells were decorin and biglycan, and TGF-PI markedly stimulated the synthesis of decorin in MC3T3-El and of biglycan in M G 63 cells. SaOS 2 and UMR 106 cells synthesized barely detectable amounts of decorin or biglycan, and TGF-P1 did not stimulate the synthesis of these proteoglycans. In SaOS 2 cells, however, TGF-P1 enhanced fibronectin synthesis. TGF-P1 did not show any of these effects in UMR 106 cells. Receptor cross-linking studies revealed that only MC3T3-EI and M G 63 cells had both types I and II signal-transducing receptors for TGF-P in addition to betaglycan. SaOS 2 cells possessed type I but no type II receptor on the cell surface. In contrast, SaOS 2 as well as MC3T3-El and M G 63 cells expressed type I 1 receptor mRNA by Northern blot analysis, and cell lysates contained type II receptor by Western blot analysis. Thus, it appears that type II receptor present in SaOS 2 cells is not able to bind TGF-PI under these conditions. UMR 106 cells with no response to TGF-PI had neither of the signaltransducing receptors by any of the analyses. These observations using clonal osteoblastic cell lines demonstrate that the ability of osteoblastic cells to synthesize bone matrix proteoglycans is associated with the responsiveness of these cells to TGF-P1, that the responsiveness of osteoblastic cells to TGF-PI in cell proliferation and proteoglycan synthesis correlates with the presence of both types I and II receptors, and that the effect of TGF-P1 on fibronectin synthesis can develop with little binding of TCF-P1 to type I 1 receptor if type I receptor is present. It is suggested that the combination of cell-surface receptors for TGF-f3 determines the responsiveness of osteoblastic cells to TGF-P and that changes in cell-surface TGF-P receptors may play a role in the regulation of matrix protein synthesis and bone formation in osteoblasts. o 1995 ~i l e y -~i s , , Inc.
📜 SIMILAR VOLUMES
A panel of 6 human glioma cell lines was examined for TGF-1 responsiveness. U-178 MG and U-251 MG AgCl1 were significantly inhibited by TGF-1, while U-343 MGa 31L and U-343 MGa 35L were potently stimulated to proliferate. TGF-1 induced endogenous PAI-1 protein synthesis, Smad binding element/(CAG
Transforming growth factor b1 (TGFb1) inhibits the growth of normal rat epithelial thyroid cells (FRTL-5 strain) by counteracting thyrotropin (TSH)-stimulated DNA synthesis and by slowing the cells in the G1 phase of the cell cycle. Here, we have studied two clones of FRTL-5 thyroid cell line transf
In mammals, transforming growth factor-beta (TGF-beta) is found in 3 highly homologous isoforms that exert their effects via heteromeric complexes of type-I and type-II receptors (TbetaR-I and TbetaR-II). TGF-beta regulates the growth and metabolism of various cell types, including keratinocytes. We
A number of studies suggest that an inverse correlation exists between the epidermal growth factor-receptor and the estrogen receptor expression in primary human breast carcinoma as well as in established human breast carcinoma cell lines. Recent studies suggest that the epidermal growth factor-rece